Reviewed by Michael Gill, B. Sc.
25 Polycystic Ovarian Syndrome Clinical Trials Near Me
Top Hospitals for Polycystic Ovarian Syndrome Clinical Trials
Image of University of Virginia in Virginia.
University of Virginia
Charlottesville
5Active Trials
7All Time Trials for Polycystic Ovarian Syndrome
2000First Polycystic Ovarian Syndrome Trial
Image of University of Virginia Center for Research in Reproduction in Virginia.
University of Virginia Center for Research in Reproduction
Charlottesville
5Active Trials
8All Time Trials for Polycystic Ovarian Syndrome
2006First Polycystic Ovarian Syndrome Trial
Top Cities for Polycystic Ovarian Syndrome Clinical Trials
Image of Philadelphia in Pennsylvania.
Philadelphia
2Active Trials
Spruce Study SiteTop Active Site
Most Recent Polycystic Ovarian Syndrome Clinical Trials
Top Treatments for Polycystic Ovarian Syndrome Clinical Trials
Treatment Name
Active Polycystic Ovarian Syndrome Clinical Trials
All Time Trials for Polycystic Ovarian Syndrome
First Recorded Polycystic Ovarian Syndrome Trial
Spironolactone
3
5
2016
Flutamide
2
5
2006
Metformin
2
71
2000
Tildacerfont
1
1
2022
AblaCare System
1
1
2022

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: October 5th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Tasali E, Leproult R, Ehrmann DA, Van Cauter E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1044-9. doi: 10.1073/pnas.0706446105. Epub 2008 Jan 2. https://pubmed.ncbi.nlm.nih.gov/181722122 Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN; PCOS/Troglitazone Study Group. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006 Jan;91(1):48-53. Epub 2005 Oct 25. https://pubmed.ncbi.nlm.nih.gov/162492843 González F. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction. Semin Reprod Med. 2015 Jul;33(4):276-86. doi: 10.1055/s-0035-1554918. Epub 2015 Jul 1. Review. https://pubmed.ncbi.nlm.nih.gov/261329324 Sopher AB, Grigoriev G, Laura D, Cameo T, Lerner JP, Chang RJ, McMahon DJ, Oberfield SE. Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents. J Pediatr Endocrinol Metab. 2014 Nov;27(11-12):1175-9. doi: 10.1515/jpem-2014-0128. https://pubmed.ncbi.nlm.nih.gov/250033765 Sopher AB, Gerken AT, Blaner WS, Root JM, McMahon DJ, Oberfield SE. Metabolic manifestations of polycystic ovary syndrome in nonobese adolescents: retinol-binding protein 4 and ectopic fat deposition. Fertil Steril. 2012 Apr;97(4):1009-15. doi: 10.1016/j.fertnstert.2012.01.111. Epub 2012 Feb 17. https://pubmed.ncbi.nlm.nih.gov/223418816 Tasali E, Van Cauter E, Ehrmann DA. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006 Jan;91(1):36-42. Epub 2005 Oct 11. https://pubmed.ncbi.nlm.nih.gov/162197197 Tasali E, Chapotot F, Leproult R, Whitmore H, Ehrmann DA. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011 Feb;96(2):365-74. doi: 10.1210/jc.2010-1187. Epub 2010 Dec 1. https://pubmed.ncbi.nlm.nih.gov/211234498 O'Mara AE, Johnson JW, Linderman JD, Brychta RJ, McGehee S, Fletcher LA, Fink YA, Kapuria D, Cassimatis TM, Kelsey N, Cero C, Sater ZA, Piccinini F, Baskin AS, Leitner BP, Cai H, Millo CM, Dieckmann W, Walter M, Javitt NB, Rotman Y, Walter PJ, Ader M, Bergman RN, Herscovitch P, Chen KY, Cypess AM. Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Invest. 2020 May 1;130(5):2209-2219. doi: 10.1172/JCI131126. https://pubmed.ncbi.nlm.nih.gov/319618269 Sopher AB, Grigoriev G, Laura D, Cameo T, Lerner JP, Chang RJ, McMahon DJ, Oberfield SE. Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents. J Pediatr Endocrinol Metab. 2014 Nov;27(11-12):1175-9. doi: 10.1515/jpem-2014-0128. https://pubmed.ncbi.nlm.nih.gov/2500337610 González F, Mather KJ, Considine RV, Abdelhadi OA, Acton AJ. Salicylate administration suppresses the inflammatory response to nutrients and improves ovarian function in polycystic ovary syndrome. Am J Physiol Endocrinol Metab. 2020 Oct 1;319(4):E744-E752. doi: 10.1152/ajpendo.00228.2020. Epub 2020 Aug 24. https://pubmed.ncbi.nlm.nih.gov/32830548